.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Harvard Business School
Moodys
Covington
Queensland Health
Cantor Fitzgerald
US Department of Justice
US Army
Colorcon
AstraZeneca

Generated: September 21, 2017

DrugPatentWatch Database Preview

Chlorpheniramine maleate; phenylpropanolamine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine maleate; phenylpropanolamine hydrochloride and what is the scope of chlorpheniramine maleate; phenylpropanolamine hydrochloride patent protection?

Chlorpheniramine maleate; phenylpropanolamine hydrochloride
is the generic ingredient in three branded drugs marketed by Novartis and Graham Dm, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate; phenylpropanolamine hydrochloride.

Summary for Generic Name: chlorpheniramine maleate; phenylpropanolamine hydrochloride

Tradenames:3
Patents:0
Applicants:2
NDAs:3
Drug Master File Entries: see list29
Clinical Trials: see list2,449
Drug Prices:see low prices
DailyMed Link:chlorpheniramine maleate; phenylpropanolamine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graham Dm
COLD CAPSULE IV
chlorpheniramine maleate; phenylpropanolamine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018793-001Apr 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
TRIAMINIC-12
chlorpheniramine maleate; phenylpropanolamine hydrochloride
TABLET, EXTENDED RELEASE;ORAL018115-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Graham Dm
COLD CAPSULE V
chlorpheniramine maleate; phenylpropanolamine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018794-001Apr 23, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Express Scripts
Federal Trade Commission
Novartis
Harvard Business School
Medtronic
McKinsey
UBS
Chubb
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot